entertainment -WSS

entertainment

author：fashion 2025-10-01 17:05:41 - browse：25652

Roche HQ — SEBASTIEN BOZON/AFP via Getty Images

The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In the wee hours of Wednesday morning, it got another.

Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.

The announcement release came hours after Evercore analyst Umer Raffat emailed investors that he had found a presentation on a Roche media portal, presumably uploaded by accident.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： What don’t we know about an Alzheimer’s drug side effect?

WSS

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Failure, not just success, should guide future doctors

'Brian's Song' at 50 still offers lessons about cancer for today

Disappointing trial forces Pfizer to pivot on obesity medicine plans

U.K. Biobank has 500,000 peoples' genome sequences available

Wikipedia

entertainment

focus

Medical leaders decry Supreme Court decision on affirmative action

Pediatric cancer treatments threatened by a new FDA policy

Moonlake's readout produced a cash windfall. Risks remain

With clinical trial data readouts, here's how to spot spin

Guidelines to prevent youth baseball injuries need more muscle

How to pay for weight loss drugs and save Medicare

Medical leaders decry Supreme Court decision on affirmative action

Feed a cold, starve a fever? Here’s what science says

Hepatitis C has a cure — but many Americans still lack access to it

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

leisure time

Takeda, Janssen join wearable maker to measure scratching

J&J to emphasize cancer drugs, stop much of its vaccine research

It was time to plan for my old age. If only I could stop crying

NFL doctors' conflicts of interest could endanger players, report says

J&J to emphasize cancer drugs, stop much of its vaccine research

Doctors are clamoring for more clarity on Paxlovid prescribing

hotspot

hotspot

hotspot

Wikipedia